IUPAC name
3,7-dimethyl-1-(5-oxohexyl)-2,3,6,7-tetrahydro-1H-purine-2,6-dione
SMILES
CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C
Compound class
Platelet Aggregation Inhibitors; Phosphodiesterase Inhibitors; Vasodilator Agents; Free Radical Scavengers; Radiation-Protective Agents; Hematologic Agents; Hemorrheologic Agents; Cardiovascular System; Peripheral Vasodilators; Purine Derivatives; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1A2 Inducers;
Therapeutic area
For the treatment of patients with intermittent lameness or immobility arising from chronic occlusive arterial disease of the limbs.
Common name
Pentoxifylline
IUPAC name
3,7-dimethyl-1-(5-oxohexyl)-2,3,6,7-tetrahydro-1H-purine-2,6-dione
SMILES
CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C
INCHI
InChI=1S/C13H18N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8H,4-7H2,1-3H3
FORMULA
C13H18N4O3
Common name
Pentoxifylline
IUPAC name
3,7-dimethyl-1-(5-oxohexyl)-2,3,6,7-tetrahydro-1H-purine-2,6-dione
Molecular weight
278.307
clogP
0.830
clogS
-2.081
HBond Acceptor
4
HBond Donor
0
Total Polar Surface Area
78.89
Number of Rings
2
Rotatable Bond
5
